Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01884077 · ClinicalTrials.gov registry record · NA
Total vs. Reverse Shoulder Replacement: Pain Relief Two Years After Surgery
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01884077: Clinical Trial NA study, sponsored by Washington University School of Medicine.
NCT01884077 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01884077, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Specific Aim: To compare early postoperative pain relief in patients over the age of 70 who undergo either Total Shoulder Arthroplasty or Reverse Shoulder Arthroplasty in treatment of glenohumeral osteoarthritis. Hypothesis: Early postoperative pain relief will be greater in those undergoing Reverse Shoulder Arthroplasty.
Primary Outcome
American Shoulder \& Elbow Survey (ASES): Assessment of patient-rated shoulder pain and function/disability. Questions involve activities of daily living that reflect the use of the shoulder \& elbow in different planes of motion. Pain and weakness with various activities are also addressed. ASES score will be calculated, compared and reported for both groups pre-operatively and 2 years post operatively: (17 patients) total arthroplasty and (17 patients) reverse arthroplasty.
Interventions
- DEVICE Reverse Shoulder Arthroplasty
- DEVICE Total Shoulder Arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-11 |
| Est. Completion | 2016-06 |
| Phase | NA |
Why NCT01884077 stopped before completion
NCT01884077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Reverse Shoulder Arthroplasty is the first listed.
NCT01884077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01884077 about?
NCT01884077 is a clinical study titled "Total vs. Reverse Shoulder Replacement: Pain Relief Two Years After Surgery". Specific Aim: To compare early postoperative pain relief in patients over the age of 70 who undergo either Total Shoulder Arthroplasty or Reverse Shoulder Arthroplasty in treatment of glenohumeral osteoarthritis. Hypothesis: Early postoperative pain relief will be greater in those undergoing Revers...
What is the current status of trial NCT01884077?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2012-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01884077?
The interventions under investigation include: Reverse Shoulder Arthroplasty (DEVICE), Total Shoulder Arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT01884077?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01884077's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia